Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors

Cancer Research

Volumn 72, Issue 2, 2012, Pages 482-490

  Diepart, Caroline ^a   Karroum, Oussama ^a   Magat, Julie ^a   Feron, Olivier ^a   Verrax, Julien ^a   Calderon, Pedro Buc ^a   Grégoire, Vincent ^a   Leveque, Philippe ^a   Stockis, Julie ^b   Dauguet, Nicolas ^b   Jordan, Bénédicte F ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; FLUORINE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; ELECTRON PARAMAGNETIC RESONANCE OXIMETRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LIVER TUMOR; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; RADIOSENSITIVITY; REOXYGENATION; SOLID TUMOR; TUMOR BLOOD FLOW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ARSENICALS; CARCINOMA, LEWIS LUNG; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; OXIDES; OXYGEN CONSUMPTION; RADIATION-SENSITIZING AGENTS;

EID: 84855865176     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1755     Document Type: Article

References (45)

1. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006;82:699-757. (Pubitemid 44832019)
2. Secomb TW, Hsu R, Ong ET, Gross JF, Dewhirst MW. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 1995;34:313-6.
3. Biaglow JE, Manevich Y, Leeper D, Chance B, Dewhirst MW, Jenkins WT, et al. MIBG inhibits respiration: potential for radio-and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 1998; 42:871-6. (Pubitemid 28559434)
4. Jordan BF, Gregoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara J, et al. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res 2002;62:3555-61. (Pubitemid 34651408)
5. Crokart N, Radermacher K, Jordan BF, Baudelet C, Cron GO, Grégoire V, et al. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Res 2005;65:7911-6. (Pubitemid 41297269)
6. Crokart N, Jordan BF, Baudelet C, Cron GO, Hotton J, Radermacher K, et al. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clin Cancer Res 2007;13: 630-5. (Pubitemid 46225370)
7. Ansiaux R, Baudelet C, Jordan BF, Crokart N, Martinive P, DeWever J, et al. Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Res 2006;66:9698-704. (Pubitemid 44623670)
8. Ansiaux R, Dewever J, Gregoire V, Feron O, Jordan BF, Gallez B. Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy. Radiat Res 2009;172:584-91.
9. Jordan BF, Christian N, Crokart N, Gregoire V, Feron O, Gallez B. Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiat Res 2007;168:428-32. (Pubitemid 351303170)
10. Zhu J, Chen Z, Lallemand-Breitenbach V, de Thé H. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2002;2: 705-13. (Pubitemid 37328921)
11. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, et al. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 2001;61:5432-40. (Pubitemid 32694923)
12. Shen ZY, Zhang Y, Chen JY, Chen MH, Shen J, Luo WH, et al. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts. Oncol Rep 2004;11: 155-9.
13. Bornstein J, Sagi S, Haj A, Harroch J, Fares F. Arsenic trioxide inhibits the growth of human ovarian carcinoma cell line. Gynecol Oncol 2005;99:726-9. (Pubitemid 41686559)
14. Woo SH, Park IC, Park MJ, Lee HC, Lee SJ, Chun YJ, et al. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int J Oncol 2002;21:57-63.
15. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res 2002;62:3893-903. (Pubitemid 34792653)
16. Xiao YF, Liu SX, Wu DD, Chen X, Ren LF. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World J Gastroenterol 2006;12: 5780-6. (Pubitemid 44594244)
17. Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, et al. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 2003;278:37832-9. (Pubitemid 37175311)
18. Gallez B, Baudelet C, Jordan BF. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed 2004;17:240-62. (Pubitemid 39268771)
19. Jordan BF, Cron GO, Gallez B. Rapid monitoring of oxygenation by 19F magnetic resonance imaging: Simultaneous comparison with fluorescence quenching. Magn Reson Med 2009;61:634-8.
20. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol 2004;386:378-418. (Pubitemid 38657603)
21. Gallez B, Jordan BF, Baudelet C, Misson PD. Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry. Magn Reson Med 1999;42: 627-30. (Pubitemid 29468290)
22. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke RH, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009;16: 1093-107.
23. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
24. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-12. (Pubitemid 11246585)
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
26. Cottet-Rousselle C, Ronot X, Leverve X, Mayol JF. Cytometric assessment of mitochondria using fluorescent probes. Cytom Part A 2011;79:405-25.
27. Robinson SP, Griffiths JR. Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philos Trans R Soc Lond B Biol Sci 2004;359: 987-96. (Pubitemid 38784084)
28. Griffin RJ, Williams BW, Park HJ, Song CW. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Int J Radiat Oncol Biol Phys 2005;61:1516-22. (Pubitemid 40470436)
29. Lew YS, Kolozsvary A, Brown SL, Kim JH. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor. Cancer Res 2002;62:4202-5. (Pubitemid 34827272)
30. Griffin RJ, Monzen H, Williams BW, Park H, Lee SH, Song CW. Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours. Int J Hyperthermia 2003;19:575-89. (Pubitemid 37406668)
31. Dewhirst MW, Cardenas Navia I, Brizel DM, Willett C, Secomb TW. Multiple etiologies of tumor hypoxia require multifaceted solutions. Clin Cancer Res 2007;13:375-7. (Pubitemid 46225338)
32. Jordan BF, Gallez B. Surrogate MR markers of response to chemo-or radiotherapy in association with co-treatments: a retrospective analysis of multi-modal studies. Contrast Media Mol Imag 2010;5: 323-32.
33. Dai J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999;93:268-77. (Pubitemid 29019412)
34. Dalton WS. Targeting the mitochondria: an exciting new approach to myeloma therapy. Clin Cancer Res 2002;8:3643-5. (Pubitemid 35424753)
35. Kim JH, Lew YS, Kolozsvary A, Ryu S, Brown SL. Arsenic trioxide enhances radiation response of 9L glioma in the rat brain. Radiat Res 2003;160:662-6. (Pubitemid 37521709)
36. Monzen H, Griffin RJ, Williams BW, Amano M, Ando S, Hasegawa T. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor. Radiat Med 2004;22:205-11. (Pubitemid 39264796)
37. Jones EL, Douple EB. The effect of in vivo GSH depletion on thermo-sensitivity, radiosensitivity and thermal radiosensitization. Int J Hyperthermia 1990;6:951-5. (Pubitemid 20308563)
38. Vuky J, Yu R, Schwartz L, Motzer RJ. Phase II clinical in patients with metastatic renal cell carcinoma. Invest New Drugs 2002;20: 327-30. (Pubitemid 34823761)
39. Kim KB, Bedikian AY, Camacho LH, Papadopoulos NE, McCullough C. A phase II trial of arsenic trioxide in patients with metastatic melanoma. Cancer 2005;104:1687-92. (Pubitemid 41437432)
40. Tarhini AA, Kirkwood JM, Tawbi H, Gooding WE, Islam MF, Agarwala SS. Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma. Cancer 2008;112:1131-8. (Pubitemid 351304599)
41. Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic oxides, gallium arsenide, and arsine: a toxicological review. Toxicol Appl Pharmacol 2003;193:309-34. (Pubitemid 37543540)
42. Kito M, Matsumoto K, Wada N, Sera K, Futatsugawa S, Naoe T, et al. Antitumor effect of arsenic trioxide in murine xenograft model. Cancer Sci 2003;94:1010-4. (Pubitemid 37508985)
43. Ning S, Knox SJ. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma. Int J Radiat Oncol Biol Phys 2006;65:493-8.
44. Xie LX, Lin XH, Li DR, Chen JY, Hong CQ, Du CW. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts. Exp Oncol 2007;29:45-8. (Pubitemid 46713479)
45. The Official document linked to the Initial Marketing Authorization of Trisenox (European Public Assessment Report - Scientific Discussion - 28/10/2005). Available from: http://www.ema.europa.eu/.